Med-IQ

#RiskTipTuesday: Is your EHR strengthening team communication? - Support efficient communication - Document calls + nontraditional encounters - Provide ongoing training for all users Stronger communication = safer care + reduced risk. #RiskTipTuesday #PatientSafety #RiskManagement

Interesting data on the tafamidis-statin interaction--> related to BCRP substrates Presented at #ACC26 #CardioTwitter #MedIQACC26

#ACC26 @premsoman123 presented in an LBCT session the updated outcomes from ATTRibute-CM OLE - patients on continuous acoramidis vs placebo to acoramidis out to 54 months. The evolution of ATTR-CM treatment is a good story to tell #CardioTwitter #MedIQACC26

Thank you to Dr. Ahmad Masri for his live updates on ATTR-CM from the American College of Cardiology's Annual Scientific Session (ACC26) this past weekend! Check out this thread for highlights.

This free accredited CME shows you how a simple, 30-second, 4-position observational exam can help: • Identify motor delays before they’re missed • Refer earlier • Unlock neuroplasticity • Give families a stronger path forward clinical.med-iq.com/activity/detec…

Interesting data on the tafamidis-statin interaction--> related to BCRP substrates Presented at #ACC26 #CardioTwitter #MedIQACC26

#ACC26 @premsoman123 presented in an LBCT session the updated outcomes from ATTRibute-CM OLE - patients on continuous acoramidis vs placebo to acoramidis out to 54 months. The evolution of ATTR-CM treatment is a good story to tell #CardioTwitter #MedIQACC26

Thank you to @MasriAhmadMD for his live updates on advances in ATTR-CM treatment from #ACC26 this past weekend! Check out this thread for highlights. #MedIQACC26